Partnering interests
At ALK, partnerships are fundamental for our continued business development. We are fueled by our commitment to innovate and continuously leverage the collective strengths of our partners to be able to deliver cutting edge treatment solutions to people living with allergy. Collaboration is key to our success, and we actively seek partners who share our dedication to developing advanced treatments and reaching more people with allergy worldwide.
By partnering with ALK, your organisation will gain access to our extensive R&D and immunology expertise, as well as our proven track record of global clinical development and commercialisation. We are currently seeking innovative preclinical or clinical stage assets in allergic or inflammatory diseases, with a strong scientific rationale and an established IP position. Furthermore, we are constantly seeking commercial partnerships outside North America and Europe.
Current partnerships
We are currently present in several countries and regions around the world through our successful and dedicated partnerships with other pharmaceutical companies – and we are open for more opportunities. See an overview of our current partnerships on the map below.
